Silk Road Medical Inc Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019
Revenue
Cost of goods sold
Gross profit
Operating expenses:
Research and development
Selling, general and administrative
Total operating expenses
Loss from operations
Interest income
Interest expense
Loss on debt extinguishment
Other income (expense), net
Net loss attributable to non-controlling interest
Net loss
Other comprehensive income (loss):
Unrealized gain on investments, net
Net change in other comprehensive loss

Net loss and comprehensive loss attributable to Silk Road Medical, Inc. common stockholders
Unrealized gain (loss) on investments, net
Other comprehensive income (loss)
Comprehensive loss
Net loss per share, basic
Net loss per share, diluted
Weighted average common shares used to compute net loss per share, basic
Weighted average common shares used to compute net loss per share, diluted

Comments